Related references
Note: Only part of the references are listed.68Ga-FAPI as a Diagnostic Tool in Sarcoma: Data from the 68Ga-FAPI PET Prospective Observational Trial
Lukas Kessler et al.
JOURNAL OF NUCLEAR MEDICINE (2022)
The added value of PSMA PET/MR radiomics for prostate cancer staging
Esteban Lucas Solari et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2022)
PSMA PET total tumor volume predicts outcome of patients with advanced prostate cancer receiving [177Lu]Lu-PSMA-617 radioligand therapy in a bicentric analysis
Robert Seifert et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2021)
Evaluation of 18F-FDG PET/CT images acquired with a reduced scan time duration in lymphoma patients using the digital biograph vision
Manuel Weber et al.
BMC CANCER (2021)
Supervised machine learning enables non-invasive lesion characterization in primary prostate cancer with [68Ga]Ga-PSMA-11 PET/MRI
L. Papp et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2021)
Deep learning-assisted ultra-fast/low-dose whole-body PET/CT imaging
Amirhossein Sanaat et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2021)
PET/MRI assessment of lung nodules in primary abdominal malignancies: sensitivity and outcome analysis
Pierpaolo Biondetti et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2021)
Artificial intelligence enables whole-body positron emission tomography scans with minimal radiation exposure
Yan-Ran (Joyce) Wang et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2021)
Just another Clever Hans? Neural networks and FDG PET-CT to predict the outcome of patients with breast cancer
Manuel Weber et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2021)
SiPM applications in positron emission tomography: toward ultimate PET time-of-flight resolution
P. Lecoq et al.
EUROPEAN PHYSICAL JOURNAL PLUS (2021)
Comparing lesion detection efficacy and image quality across different PET system generations to optimize the iodine-124 PET protocol for recurrent thyroid cancer
David Kersting et al.
EJNMMI PHYSICS (2021)
Prospective comparison of the diagnostic accuracy of 18F-FDG PET/MRI, MRI, CT, and bone scintigraphy for the detection of bone metastases in the initial staging of primary breast cancer patients
Nils Martin Bruckmann et al.
EUROPEAN RADIOLOGY (2021)
Use of PET Imaging in Neuro-Oncological Surgery
Adrien Holzgreve et al.
CANCERS (2021)
Soft tissue and visceral sarcomas: ESMO-EURACAN-GENTURIS Clinical Practice Guidelines for diagnosis, treatment and follow-up
A. Gronchi et al.
ANNALS OF ONCOLOGY (2021)
Focal unspecific bone uptake on [18F]-PSMA-1007 PET: a multicenter retrospective evaluation of the distribution, frequency, and quantitative parameters of a potential pitfall in prostate cancer imaging
Hannes Gruenig et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2021)
Clinical insignificance of [18F]PSMA-1007 avid non-specific bone lesions: a retrospective evaluation
Evyn G. Arnfield et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2021)
The Additive Diagnostic Value of Prostate-specific Membrane Antigen Positron Emission Tomography Computed Tomography to Multiparametric Magnetic Resonance Imaging Triage in the Diagnosis of Prostate Cancer (PRIMARY): A Prospective Multicentre Study
Louise Emmett et al.
EUROPEAN UROLOGY (2021)
Determining the Axillary Nodal Status with 4 Current Imaging Modalities, Including 18F-FDG PET/MRI, in Newly Diagnosed Breast Cancer: A Comparative Study Using Histopathology as the Reference Standard
Janna Morawitz et al.
JOURNAL OF NUCLEAR MEDICINE (2021)
Lutetium-177-PSMA-617 for Metastatic Castration-Resistant Prostate Cancer
Oliver Sartor et al.
NEW ENGLAND JOURNAL OF MEDICINE (2021)
Evaluation of 68Ga-PSMA-11 PET-MRI in Patients with Advanced Prostate Cancer Receiving 177Lu-PSMA-617 Therapy: A Radiomics Analysis
Wolfgang Roll et al.
CANCERS (2021)
Multiparametric Integrated 18F-FDG PET/MRI-Based Radiomics for Breast Cancer Phenotyping and Tumor Decoding
Lale Umutlu et al.
CANCERS (2021)
Image Quality and Semiquantitative Measurements on the Biograph Vision PET/CT System: Initial Experiences and Comparison with the Biograph mCT
Joyce van Sluis et al.
JOURNAL OF NUCLEAR MEDICINE (2020)
Multiparametric MRI for prostate cancer diagnosis: current status and future directions
Armando Stabile et al.
NATURE REVIEWS UROLOGY (2020)
Detection Rate and Localization of Prostate Cancer Recurrence Using 68Ga-PSMA-11 PET/MRI in Patients with Low PSA Values ≤ 0.5 ng/mL
Benedikt Kranzbuehler et al.
JOURNAL OF NUCLEAR MEDICINE (2020)
Non-invasive tumor decoding and phenotyping of cerebral gliomas utilizing multiparametric 18F-FET PET-MRI and MR Fingerprinting
Johannes Haubold et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2020)
Radioligand therapy using [177Lu]Lu-PSMA-617 in mCRPC: a pre-VISION single-center analysis
Robert Seifert et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2020)
Usefulness of Hybrid PET/MRI in Clinical Evaluation of Head and Neck Cancer Patients
Natalia Samolyk-Kogaczewska et al.
CANCERS (2020)
Prospective evaluation of whole-body MRI and 18F-FDG PET/MRI in N and M staging of primary breast cancer patients
Nils Martin Bruckmann et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2020)
LSemiautomatically Quantified Tumor Volume Using 68Ga-PSMA-11 PET as a Biomarker for Survival in Patients with Advanced Prostate Cancer
Robert Seifert et al.
JOURNAL OF NUCLEAR MEDICINE (2020)
Validation of diffusion MRI phenotypes for predicting response to bevacizumab in recurrent glioblastoma: post-hoc analysis of the EORTC-26101 trial
Marianne Schell et al.
NEURO-ONCOLOGY (2020)
5th ESO-ESMO international consensus guidelines for advanced breast cancer (ABC 5)
F. Cardoso et al.
ANNALS OF ONCOLOGY (2020)
18F-FDG PET/MRI in adult sarcomas
Gianluca Cassarino et al.
CLINICAL AND TRANSLATIONAL IMAGING (2020)
Analysis of PSMA expression and outcome in patients with advanced Prostate Cancer receiving 177 Lu-PSMA-617 Radioligand Therapy
Robert Seifert et al.
THERANOSTICS (2020)
68Ga-PSMA-11 PET/CT in prostate cancer patients with biochemical recurrence after radical prostatectomy and PSA <0.5 ng/ml. Efficacy and impact on treatment strategy
Andrea Farolfi et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2019)
18F-FDG PET/MRI for Therapy Response Assessment of Isolated Limb Perfusion in Patients with Soft-Tissue Sarcomas
Johannes Grueneisen et al.
JOURNAL OF NUCLEAR MEDICINE (2019)
Early breast cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
F. Cardoso et al.
ANNALS OF ONCOLOGY (2019)
Recurrent glioblastoma versus late posttreatment changes: diagnostic accuracy of O-(2-[18F]fluoroethyl)-L-tyrosine positron emission tomography (18F-FET PET)
Asma Bashir et al.
NEURO-ONCOLOGY (2019)
Joint EANM/EANO/RANO practice guidelines/SNMMI procedure standards for imaging of gliomas using PET with radiolabelled amino acids and [18F]FDG: version 1.0
Ian Law et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2019)
Comparison of image quality and lesion detection between digital and analog PET/CT
Diego Alfonso Lopez-Mora et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2019)
Predictive value of pretreatment MRI texture analysis in patients with primary nasopharyngeal carcinoma
Jiaji Mao et al.
EUROPEAN RADIOLOGY (2019)
The new opportunities for high time resolution clinical TOF PET
Maurizio Conti et al.
CLINICAL AND TRANSLATIONAL IMAGING (2019)
Local recurrence of squamous cell carcinoma of the head and neck after radio(chemo)therapy: Diagnostic performance of FDG-PET/MRI with diffusion-weighted sequences
Minerva Becker et al.
EUROPEAN RADIOLOGY (2018)
Prostate Cancer Molecular Imaging Standardized Evaluation (PROMISE): Proposed miTNM Classification for the Interpretation of PSMA-Ligand PET/CT
Matthias Eiber et al.
JOURNAL OF NUCLEAR MEDICINE (2018)
4th ESO-ESMO International Consensus Guidelines for Advanced Breast Cancer (ABC 4)
F. Cardoso et al.
ANNALS OF ONCOLOGY (2018)
68Ga-Prostate-Specific Membrane Antigen PET/CT in Triple-Negative Breast Cancer
Averilicia Passah et al.
CLINICAL NUCLEAR MEDICINE (2018)
Comparison of the clinical performance of upper abdominal PET/DCE-MRI with and without concurrent respiratory motion correction (MoCo)
Onofrio A. Catalano et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2018)
Clinical utility of simultaneous whole-body F-18-FDG PET/MRI as a single-step imaging modality in the staging of primary nasopharyngeal carcinoma
Sheng-Chieh Chan et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2018)
Concurrent Respiratory Motion Correction of Abdominal PET and Dynamic Contrast-Enhanced-MRI Using a Compressed Sensing Approach
Niccolo Fuin et al.
JOURNAL OF NUCLEAR MEDICINE (2018)
Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
Freddie Bray et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2018)
68Ga-Prostate-Specific Membrane Antigen PET/CT and 18F-FDG PET/CT of Primary Signet Ring Cell Breast Adenocarcinoma
Ashwin Singh Parihar et al.
CLINICAL NUCLEAR MEDICINE (2018)
Local and whole-body staging in patients with primary breast cancer: a comparison of one-step to two-step staging utilizing F-18-FDG-PET/MRI
Julian Kirchner et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2018)
Predicting IDH genotype in gliomas using FET PET radiomics
Philipp Lohmann et al.
SCIENTIFIC REPORTS (2018)
Interdisciplinary Screening, Diagnosis, Therapy and Follow-up of Breast Cancer. Guideline of the DGGG and the DKG (S3-Level, AWMF Registry Number 032/045OL, December 2017) - Part 2 with Recommendations for the Therapy of Primary, Recurrent and Advanced Breast Cancer
Achim Woeckel et al.
GEBURTSHILFE UND FRAUENHEILKUNDE (2018)
Integrated 18F-FDG PET/MRI compared to MRI alone for identification of local recurrences of soft tissue sarcomas: a comparison trial
Youssef Erfanian et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2017)
Staging performance of whole-body DWI, PET/CT and PET/MRI in invasive ductal carcinoma of the breast
Onofrio Antonio Catalano et al.
INTERNATIONAL JOURNAL OF ONCOLOGY (2017)
Octreotide therapy in meningiomas: in vitro study, clinical correlation, and literature review
Thomas Graillon et al.
JOURNAL OF NEUROSURGERY (2017)
Current Clinical Brain Tumor Imaging
Javier E. Villanueva-Meyer et al.
NEUROSURGERY (2017)
Comparison of 68Ga-HBED-CCPSMA-PET/CT and multiparametric MRI for gross tumour volume detection in patients with primary prostate cancer based on slice by slice comparison with histopathology
Constantinos Zamboglou et al.
THERANOSTICS (2017)
Promises and challenges for the implementation of computational medical imaging (radiomics) in oncology
E. J. Limkin et al.
ANNALS OF ONCOLOGY (2017)
PET/MR in invasive ductal breast cancer: correlation between imaging markers and histological phenotype
Onofrio Antonio Catalano et al.
BRITISH JOURNAL OF CANCER (2017)
FDG PET/MR in initial staging of sarcoma: Initial experience and comparison with conventional imaging
Ivan Platzek et al.
CLINICAL IMAGING (2017)
Outcome of Small Lung Nodules Missed on Hybrid PET/MRI in Patients With Primary Malignancy
Roy A. Raad et al.
JOURNAL OF MAGNETIC RESONANCE IMAGING (2016)
Evaluation of 18F-FDG PET/MRI, 18F-FDG PET/CT, MRI, and CT in whole-body staging of recurrent breast cancer
Lino M. Sawicki et al.
EUROPEAN JOURNAL OF RADIOLOGY (2016)
18F-FDG PET/CT and PET/MRI Perform Equally Well in Cancer: Evidence from Studies on More Than 2,300 Patients
Claudio Spicks et al.
JOURNAL OF NUCLEAR MEDICINE (2016)
Correlation of Intraprostatic Tumor Extent with 68Ga-PSMA Distribution in Patients with Prostate Cancer
Kambiz Rahbar et al.
JOURNAL OF NUCLEAR MEDICINE (2016)
Comparison of Whole-Body 18F FDG PET/MR Imaging and Whole-Body 18F FDG PET/CT in Terms of Lesion Detection and Radiation Dose in Patients with Breast Cancer
Amy N. Melsaether et al.
RADIOLOGY (2016)
Radiomics: Images Are More than Pictures, They Are Data
Robert J. Gillies et al.
RADIOLOGY (2016)
Comparison of CE-FDG-PET/CT with CE-FDG-PET/MR in the evaluation of osseous metastases in breast cancer patients
O. A. Catalano et al.
BRITISH JOURNAL OF CANCER (2015)
Correlation of 18F-fluoroethyl tyrosine positron-emission tomography uptake values and histomorphological findings by stereotactic serial biopsy in newly diagnosed brain tumors using a refined software tool
William Omar Contreras Lopez et al.
ONCOTARGETS AND THERAPY (2015)
A Robust Deep Model for Improved Classification of AD/MCI Patients
Feng Li et al.
IEEE JOURNAL OF BIOMEDICAL AND HEALTH INFORMATICS (2015)
Radiation-induced cancer: a modern view
D. J. Shah et al.
BRITISH JOURNAL OF RADIOLOGY (2012)
Detection of cranial meningiomas: comparison of 68Ga-DOTATOC PET/CT and contrast-enhanced MRI
Ali Afshar-Oromieh et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2012)
Assessment of Treatment Response in Patients with Glioblastoma Using O-(2-18F-Fluoroethyl)-L-Tyrosine PET in Comparison to MRI
Norbert Galldiks et al.
JOURNAL OF NUCLEAR MEDICINE (2012)
Losartan Slows Pancreatic Tumor Progression and Extends Survival of SPARC-Null Mice by Abrogating Aberrant TGFβ Activation
Shanna A. Arnold et al.
PLOS ONE (2012)
A Comparative Study of Fused FDG PET/MRI, PET/CT, MRI, and CT Imaging for Assessing Surrounding Tissue Invasion of Advanced Buccal Squamous Cell Carcinoma
Shu-Hua Huang et al.
CLINICAL NUCLEAR MEDICINE (2011)
IDH1 and IDH2 Mutations in Gliomas
Hai Yan et al.
NEW ENGLAND JOURNAL OF MEDICINE (2009)
An overview of prognostic factors for long-term survivors of breast cancer
Isabelle Soerjomataram et al.
BREAST CANCER RESEARCH AND TREATMENT (2008)
Use of 11C-methionine PET to monitor the effects of temozolomide chemotherapy in malignant gliomas
N Galldiks et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2006)
Prognostic and predictive factors in early-stage breast cancer
M Cianfrocca et al.
ONCOLOGIST (2004)